In the treatment of patients, the WHO recommends that testing be done to determine to what medications the bacteria are sensitive and that the regimen for a known case of MDR-TB must include at least five agents belonging to different families of drugs.
Three countries - Andorra, Iceland and Malta - had no cases of resistance to first-line drugs, while in the United States, Hong Kong and Cuba, the cases of MDR TB showed a decline.